Search Results 121-130 of 16857 for CLL

  1. Resources - B-Cell Lymphoproliferative Disorders - Mayo Clinic Research

    Slager's B-Cell Lymphoproliferative Disorders Laboratory, including information about chronic lymphocytic leukemia, lymphoma, multiple myeloma, the National ...

  2. White Blood Cell Disorders Clinical Trials - Mayo Clinic Research

    ... chronic lymphocytic leukemia (CLL). A Study of Ruxolitinib for the Treatment of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell ...

  3. Clinical trials - Oncology (Medical)

    ... chronic lymphocytic leukemia (CLL). This study will also allow participants who are currently progressing on a Bruton tyrosine kinase inhibitor (BTKi) and ...

  4. Mazie Tsang, M.D. - Mayo Clinic Faculty Profiles

    Focus areas · Decision-making for older adults with advanced cancers. Dr. · Managing older adults with chronic lymphocytic leukemia (CLL). CLL mainly affects ...

  5. Asher A. Chanan-Khan, M.D. - Mayo Clinic Faculty Profiles

    Mayo Clinic researcher Asher A. Chanan-Khan, M.D., investigates treatments for chronic lymphocytic leukemia (CLL), Waldenstrom macroglobulinemia and ...

  6. Clinical trials - Oncology (Medical)

    ... chronic lymphocytic leukemia (CLL)/ small lymphocytic lymphoma (SLL), Richter's transformation, marginal zone lymphoma (MZL), mantle cell lymphoma (MCL) ...

  7. A Study to Evaluate Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia - Mayo Clinic

    Giving ibrutinib and obinutuzumab with venetoclax may work better at treating chronic lymphocytic leukemia. Participation eligibility. Participant eligibility ...

  8. Combination Therapy of Acalabrutinib, Venetoclax and Durvalumab to Treat Richter Transformation - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...

  9. Hematology - Clinical trials

    ... chronic lymphocytic leukemia (CLL). This study will also allow participants who are currently progressing on a Bruton tyrosine kinase inhibitor (BTKi) and ...

  10. A Study to Assess Monoclonal B-cell Lymphocytosis in Individuals with Chronic Hepatitis C - Mayo Clinic

    To determine the correlation between the specific subtype of MBL (CD5- MBL, atypical CLL-phenotype MBL and CLL-phenotype MBL) relative to the HCV genotype.